Suchergebnisse - "Siddique, Hifzur R"

PubPharm (26)

1

Lupeol, an androgen receptor inhibitor, enhances the chemosensitivity of prostate cancer stem cells to antiandrogen enzalutamide-based therapy

enthalten in: Toxicology and applied pharmacology | 2023

von Khan, M. | Singh, D. | Jameel, M. | +4

2

Role of epigenetic drugs in sensitizing cancers to anticancer therapies : emerging trends and clinical advancements

enthalten in: Epigenomics | 2023

von Singh, D. | Khan, M. | Siddique, H.

3

AURORA KINASE A and related downstream molecules : A potential network for cancer therapy

enthalten in: Advances in protein chemistry and structural biology | 2023

von Fatma, H. | Siddique, H.

4

Epigenetic modifications of c-MYC : Role in cancer cell reprogramming, progression and chemoresistance

enthalten in: Seminars in cancer biology | 2022

von Fatma, H. | Maurya, S. | Siddique, H.

5

Apigenin alleviates cancer drug Sorafenib induced multiple toxic effects in Swiss albino mice via anti-oxidative stress

enthalten in: Toxicology and applied pharmacology | 2022

von Singh, D. | Khan, M. | Akhtar, K. | +2

6

Biophysical binding profile with ct-DNA and cytotoxic studies of a modulated nanoconjugate of umbelliferone cobalt oxide loaded on graphene oxide (GO) as drug carrier

enthalten in: Journal of biomolecular structure & dynamics | 2022

von Yousuf, S. | Arjmand, F. | Siddique, H. | +3

7

Specific targeting of cancer stem cells by immunotherapy : A possible stratagem to restrain cancer recurrence and metastasis

enthalten in: Biochemical pharmacology | 2022

von Singh, D. | Khan, M. | Siddique, H.

8

Role of p53-miRNAs circuitry in immune surveillance and cancer development : A potential avenue for therapeutic intervention

enthalten in: Seminars in cell & developmental biology | 2022

von Singh, D. | Khan, M. | Siddique, H.

9

The multiple faces of NANOG in cancer : a therapeutic target to chemosensitize therapy-resistant cancers

enthalten in: Epigenomics | 2021

von Fatma, H. | Siddique, H. | Maurya, S.

10

Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression : Serum and Biopsy S100A4 as a Clinical Predictor

enthalten in: Molecular cancer therapeutics | 2020

von Ganaie, A. | Mansini, A. | Hussain, T. | +11